Abstract:Progressive supranuclear palsy (PSP) is a neurodegenerative tauopathy that presents with highly heterogenous clinical syndromes. We perform cross-sectional data-driven discovery of independent patterns of brain atrophy and hypometabolism across the entire PSP spectrum. We then use these patterns to predict specific clinical features and to assess their relationship to phenotypic heterogeneity. We included 111 patients with PSP (60 with Richardson syndrome and 51 with cortical and subcortical variant subtypes). Ninety-one were used as the training set and 20 as a test set. The presence and severity of granular clinical variables such as postural instability, parkinsonism, apraxia and supranuclear gaze palsy were noted. Domains of akinesia, ocular motor impairment, postural instability and cognitive dysfunction as defined by the Movement Disorders Society criteria for PSP were also recorded. Non-negative matrix factorization was used on cross-sectional MRI and fluorodeoxyglucose-positron emission tomography (FDG-PET) scans. Independent models for each as well as a combined model for MRI and FDG-PET were developed and used to predict the granular clinical variables. Both MRI and FDG-PET were better at predicting presence of a symptom than severity, suggesting identification of disease state may be more robust than disease stage. FDG-PET predicted predominantly cortical abnormalities better than MRI such as ideomotor apraxia, apraxia of speech and frontal dysexecutive syndrome. MRI demonstrated prediction of cortical and more so sub-cortical abnormalities, such as parkinsonism. Distinct neuroanatomical foci were predictive in MRI- and FDG-PET-based models. For example, vertical gaze palsy was predicted by midbrain atrophy on MRI, but frontal eye field hypometabolism on FDG-PET. Findings also differed by scale or instrument used. For example, prediction of ocular motor abnormalities using the PSP Saccadic Impairment Scale was stronger than with the Movement Disorders Society Diagnostic criteria for PSP oculomotor impairment designation. Combination of MRI and FDG-PET demonstrated enhanced detection of parkinsonism and frontal syndrome presence and apraxia, cognitive impairment and bradykinesia severity. Both MRI and FDG-PET patterns were able to predict some measures in the test set; however, prediction of global cognition measured by Montreal Cognitive Assessment was the strongest. MRI predictions generalized more robustly to the test set. PSP leads to neurodegeneration in motor, cognitive and ocular motor networks at cortical and subcortical foci, leading to diverse yet overlapping clinical syndromes. To advance understanding of phenotypic heterogeneity in PSP, it is essential to consider data-driven approaches to clinical neuroimaging analyses.

Gray matter atrophy in progressive supranuclear palsy: meta-analysis of voxel-based morphometry studies

Brain Gray Matter Abnormalities in Progressive Supranuclear Palsy Revisited.

Voxel-Wise Meta-Analysis Of Gray Matter Anomalies In Progressive Supranuclear Palsy Using Anatomic Likelihood Estimation

Voxelwise meta-analysis of white matter abnormalities in progressive supranuclear palsy

Grey Matter Volume Reduction in the Frontotemporal Cortex Associated with Persistent Verbal Auditory Hallucinations in Chinese Patients with Chronic Schizophrenia: Insights from a 3 T Magnetic Resonance Imaging Study

Grey Matter Abnormalities in Parkinson's Disease: a Voxel-Wise Meta-Analysis.

Gray Matter Atrophy in Behavioral Variant Frontotemporal Dementia: A Meta-Analysis of Voxel-Based Morphometry Studies

Gray Matter Atrophy in Parkinson's Disease and the Parkinsonian Variant of Multiple System Atrophy: A Combined ROI- and Voxel-Based Morphometric Study

Motor and extra-motor gray matter atrophy in amyotrophic lateral sclerosis: quantitative meta-analyses of voxel-based morphometry studies

Voxel-Based Meta-Analysis of Gray Matter Abnormalities in Multiple System Atrophy

Voxel-based Meta-Analysis of Grey Matter Changes in Alzheimer’s Disease

Different Patterns of Gray Matter Density in Early- and Middle-Late-onset Parkinson’s Disease: a Voxel-Based Morphometry Study

Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson’s disease

Progressive gray matter atrophy in parkinsonian variant of multiple system atrophy assessed by using causal structural covariance network

Clinical and MRI analysis of progressive supranuclear palsy：a report of 12 cases

Retinal Thinning as a Marker of Disease Severity in Progressive Supranuclear Palsy

Voxel-based morphometry MRI study of gray matter change in patients with Parkinson's disease

Patterns of brain volume and metabolism predict clinical features in the progressive supranuclear palsy spectrum

Progressive brain changes in Parkinson's disease: A meta-analysis of structural magnetic resonance imaging studies.

Progressive brain changes in Parkinson’s disease: A meta-analysis of structural magnetic resonance imaging studies

Grey Matter Volume Changes over the Whole Brain in Amyotrophic Lateral Sclerosis: A Voxel-Wise Meta-Analysis of Voxel Based Morphometry Studies